C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2491067
Described herein are methods and kits for prognosis of prostate cancer in a subject. The methods comprises: (a) determining the ratio of PCA3 and PSA expression in a urine sample and (b) correlating the value of the PCA3/PSA ratio with the aggressiveness and mortality risk of prostate cancer in the subject. Kits for prognosing prostate cancer are also described.
Hessels Daphne
Schalken Jack A.
Verhaegh Gerald
Witjes J. Alfred
Goudreau Gage Dubuc
Hessels Daphne
Schalken Jack A.
Stichting Katholieke Universiteit
Verhaegh Gerald
LandOfFree
Mrna rations in urinary sediments and/or urine as a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mrna rations in urinary sediments and/or urine as a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mrna rations in urinary sediments and/or urine as a... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2048204